Accenture to Help Santen Pharmaceutical Build a Global Intelligent Enterprise Platform on SAP® S/4HANA® to Drive Its Digital Transformation

TOKYO; Oct. 30, 2019 – Accenture (NYSE: ACN) has been selected to help Santen Pharmaceutical Co., Ltd. (Santen), an ophthalmic pharmaceutical company headquartered in Japan, build a global intelligent enterprise platform that will drive the company’s digital transformation.

Comments

Popular posts from this blog

Add Custom Field in Output of Standard Report of ME2N

UK to Receive Egyptian LNG Cargo

HANA Housekeeping using HANACleaner